Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202402391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yeonsue Jang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urological Science Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Fibrosis, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education of the Republic of Korea, National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Peritumoral fibrosis is known to promote cancer progression and confer treatment resistance in various solid tumors. Consequently, developing accurate cancer research and drug screening models that replicate the structure and function of a fibrosis‐surrounded tumor mass is imperative. Previous studies have shown that self‐assembly three‐dimensional (3D) co‐cultures primarily produce cancer‐encapsulated fibrosis or maintain a fibrosis‐encapsulated tumor mass for a short period, which is inadequate to replicate the function of fibrosis, particularly as a physical barrier. To address this limitation, a multi‐layer spheroid formation method is developed to create a fibrosis‐encapsulated tumoroid (FET) structure that maintains structural stability for up to 14 days. FETs exhibited faster tumor growth, higher expression of immunosuppressive cytokines, and equal or greater resistance to anticancer drugs compared to their parental tumoroids. Additionally, FETs serve as a versatile model for traditional cancer research, enabling the study of exosomal miRNA and gene functions, as well as for mechanobiology research when combined with alginate hydrogel. Our findings suggest that the FET represents an advanced model that more accurately mimics solid cancer tissue with peritumoral fibrosis. It may show potential superiority over self‐assembly‐based 3D co‐cultures for cancer research and drug screening, and holds promise for personalized drug selection in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urological Science Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Department of Pathology, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.
ORCID-Profile: Baek Gil Kim
Förderung
- Ministry of Education of the Republic of Korea
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Education
Zitieren
APA
Jang, Y., Kang, S., Han, H., Kang, C. M., Cho, N. H., & Kim, B. G. (2024). Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402391
Vancouver
Jang Y, Kang S, Han H, Kang CM, Cho NH, Kim BG. Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402391
BibTeX
@article{Jang2024,
author = {Jang, Yeonsue and Kang, Suki and Han, Hyunho and Kang, Chang Moo and Cho, Nam Hoon and Kim, Baek Gil},
title = {Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202402391}
}
EUVIMED